The Marketing Group PLC (ASX:2MG)
A debt free, profit generating, NASDAQ-listed company has become the world’s leading digital marketing and advertising agglomeration in just under a year.
This agglomeration is a cluster of independently run businesses in the marketing and advertising space that can draw on each other’s skills, talent and expertise, while benefitting from the liquidity of being under a publicly listed umbrella.
Essentially, this company is building a powerhouse of profitable agencies that can compete with all of the world’s majors marketing and advertising agencies.
It is achieving this goal at a rapid pace. Having grown from four companies to 19 in its initial 100 days in operation, the company is likely to have four more businesses under its belt before Christmas giving it reach into 10 countries, serving clients across the United States, Europe, Asia, Australia, and New Zealand.
This company is listed on the NASDAQ First North Stockholm exchange, and recently commenced trading on the Frankfurt Stock Exchange, one of the largest exchanges in the world.
Its listing into the Frankfurt exchange is expected to further accelerate this company’s growth, by expanding its shareholder base, increasing liquidity and introducing it to a wider European audience, potentially increasing its revenue base which has already multiplied six times from Q2 to quarter Q3 this year.
The information on this page should not be the only trigger for your investment decision. Click on the links below for a more in-depth and informed examination of the company. We strongly recommend you seek professional financial advice whenever making financial investment decisions.
This is a highly scalable business, with an aggressive acquisition strategy of highly profitable companies that has seen it grow exponentially in a very short amount of time.
That growth is expected to continue as these individually operated companies join forces to create one superpower with the capacity to play in the major marketing leagues.
ASX Junior’s Under-Drilled Cuban Oil Asset Puts it in Multi-Billion Barrel Company
Nov 15, 2018
Zero Safety Issues for IMU’s Immunotherapy Cancer Treatment: Phase II Trial Imminent
Nov 13, 2018